Investors Investors

Stock Quote

NASDAQ: PGNX
$10.36
+ 0.12
4:00 PM ET on February 24

Analyst Coverage

Firm Analyst
Aegis Capital Corp   Jason Wittes
BTIG   Timothy Chiang
Jefferies   Gena Wang, PhD
Needham & Company, LLC   Chad Messer, Ph.D.
Opus National Capital Markets   Jonathan Aschoff, PhD

Progenics Pharmaceuticals, Inc. is followed by the analyst(s) listed above. Please note that any opinions, estimates or forecasts regarding Progenics Pharmaceuticals, Inc.'s performance made by these analysts are theirs alone and do not represent opinions, forecasts or predictions of Progenics Pharmaceuticals, Inc. or its management. Progenics Pharmaceuticals, Inc. does not by its reference above or distribution imply its endorsement of or concurrence with such information, conclusions or recommendations.